{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:58:33Z","timestamp":1790269113141,"version":"4.1.0"},"reference-count":122,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Lung organoids have emerged as a promising tool for studying lung development, function, and disease pathology. The present study aimed to analyze the current status and development trends of lung organoid research over the past years, present visual representations, and provide references for future research directions using bibliometric analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Information on articles on lung organoids extracted from the Web of Science Core Collection, such as year of publication, journal, country, institution, author, and keywords, was analyzed. R, VOSviewer, and SCImago Graphica were used to visualize publication trends, co-authorship analysis, co-occurrence analysis, and hotspot evolution.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The number of global publications has increased from 1 in 2011 to 929 in 2024. The Nature produced the highest number of citations (2,675 citations). The United States (8,155 citations and 281 publications), University Medical Center Utrecht (2083 citations and 11 publications), and Clevers H (2,711 citations and 21 publications) were the most influential countries, institutions, and authors, respectively. Co-occurrence cluster analysis of the top 54 keywords formed four clusters: (1) idiopathic pulmonary fibrosis, (2) lung cancer, (3) cystic fibrosis, (4) COVID-19.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Overall, research on lung organoids continues to increase. The United States of America and the Netherlands dominated global studies. The analysis of pulmonary fibrosis, lung cancer and COVID-19 occupied a prominent position of research in this area. The research hotspots for lung organoids are disease model and microphysiological systems. Standardization, accurate disease modeling, and ethics and safety remain pressing challenges that need to be addressed in this field.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1611304","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T04:12:11Z","timestamp":1752639131000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Advancing lung organoids toward clinical applications: a global perspective on research focus and future directions"],"prefix":"10.3389","volume":"12","author":[{"given":"Qian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengming","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liting","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifeng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s12964-023-01332-9","article-title":"Applications of lung cancer organoids in precision medicine: from bench to bedside","volume":"21","author":"Li","year":"2023","journal-title":"Cell Commun Signal"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/ncb3312","article-title":"Organoids as an in vitro model of human development and disease","volume":"18","author":"Fatehullah","year":"2016","journal-title":"Nat Cell Biol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1242\/dev.140103","article-title":"Lung organoids: current uses and future promise","volume":"144","author":"Barkauskas","year":"2017","journal-title":"Development"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.molmed.2021.09.008","article-title":"Organoid models: assessing lung cell fate decisions and disease responses","volume":"27","author":"Liberti","year":"2021","journal-title":"Trends Mol Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1042\/BST20190569","article-title":"Three-dimensional models of the lung: past, present and future: a mini review","volume":"50","author":"Sen","year":"2022","journal-title":"Biochem Soc Trans"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.trsl.2022.07.002","article-title":"Human lung organoids as a model for respiratory virus replication and countermeasure performance in human hosts","volume":"250","author":"Edwards","year":"2022","journal-title":"Transl Res"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"20417314241232502","DOI":"10.1177\/20417314241232502","article-title":"Advanced lung organoids for respiratory system and pulmonary disease modeling","volume":"15","author":"Joo","year":"2024","journal-title":"J Tissue Eng"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s13770-024-00628-2","article-title":"Lung organoids: systematic review of recent advancements and its future perspectives","volume":"21","author":"Thangam","year":"2024","journal-title":"Tissue Eng Regen Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.lungcan.2022.08.006","article-title":"Organoids in lung cancer: a teenager with infinite growth potential","volume":"172","author":"Xu","year":"2022","journal-title":"Lung Cancer"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"105897","DOI":"10.1016\/j.ssci.2022.105897","article-title":"Bibliometric and scientometric analysis-based review of construction safety and health research in developing countries from 1990 to 2021","volume":"156","author":"Umeokafor","year":"2022","journal-title":"Saf Sci"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00296-024-05535-2","article-title":"Systemic sclerosis associated respiratory involvement: Scopus-based analysis of articles in 2013-2022","volume":"44","author":"Doskaliuk","year":"2024","journal-title":"Rheumatol Int"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/224953a0","article-title":"Bradford's law and the bibliography of science","volume":"224","author":"Brookes","year":"1969","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"giz053","DOI":"10.1093\/gigascience\/giz053","article-title":"Over-optimization of academic publishing metrics: observing Goodhart's law in action","volume":"8","author":"Fire","year":"2019","journal-title":"Gigascience"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"16569","DOI":"10.1073\/pnas.0507655102","article-title":"An index to quantify an individual's scientific research output","volume":"102","author":"Hirsch","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.3390\/rs14163967","article-title":"Bibliometric analysis of global NDVI research trends from 1985 to 2021","volume":"14","author":"Xu","year":"2022","journal-title":"Remote Sens"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"E1723","DOI":"10.1073\/pnas.1403470111","article-title":"Generation of multiciliated cells in functional airway epithelia from human induced pluripotent stem cells","volume":"111","author":"Firth","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e05098","DOI":"10.7554\/eLife.05098","article-title":"In vitro generation of human pluripotent stem cell derived lung organoids","volume":"4","author":"Dye","year":"2015","journal-title":"eLife"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.stemcr.2017.11.012","article-title":"In vitro induction and in vivo engraftment of lung bud tip progenitor cells derived from human pluripotent stem cells","volume":"10","author":"Miller","year":"2018","journal-title":"Stem Cell Reports"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e00723","DOI":"10.1128\/mBio.00723-19","article-title":"Authentic modeling of human respiratory virus infection in human pluripotent stem cell-derived lung organoids","volume":"10","author":"Porotto","year":"2019","journal-title":"MBio"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e100300","DOI":"10.15252\/embj.2018100300","article-title":"Long-term expanding human airway organoids for disease modeling","volume":"38","author":"Sachs","year":"2019","journal-title":"EMBO J"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1016\/j.celrep.2019.05.077","article-title":"Modeling of fibrotic lung disease using 3D organoids derived from human pluripotent stem cells","volume":"27","author":"Strikoudis","year":"2019","journal-title":"Cell Rep"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41586-022-05594-0","article-title":"FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2","volume":"615","author":"Brevini","year":"2023","journal-title":"Nature"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.3390\/cells11172758","article-title":"Lung organoids as model to study SARS-CoV-2 infection","volume":"11","author":"Peng","year":"2022","journal-title":"Cells"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41586-020-3014-1","article-title":"Progenitor identification and SARS-CoV-2 infection in human distal lung organoids","volume":"588","author":"Salahudeen","year":"2020","journal-title":"Nature"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41421-021-00346-2","article-title":"Establishment of human distal lung organoids for SARS-CoV-2 infection","volume":"7","author":"Wang","year":"2021","journal-title":"Cell Discov"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/ncb3510","article-title":"A three-dimensional model of human lung development and disease from pluripotent stem cells","volume":"19","author":"Chen","year":"2017","journal-title":"Nat Cell Biol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41586-022-04541-3","article-title":"Human distal lung maps and lineage hierarchies reveal a bipotent progenitor","volume":"604","author":"Kadur Lakshminarasimha Murthy","year":"2022","journal-title":"Nature"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/s41596-018-0104-8","article-title":"Generation of lung organoids from human pluripotent stem cells in vitro","volume":"14","author":"Miller","year":"2019","journal-title":"Nat Protoc"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e19732","DOI":"10.7554\/eLife.19732","article-title":"A bioengineered niche promotes in vivo engraftment and maturation of pluripotent stem cell derived human lung organoids","volume":"5","author":"Dye","year":"2016","journal-title":"eLife"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"119757","DOI":"10.1016\/j.biomaterials.2020.119757","article-title":"Human lung organoids develop into adult airway-like structures directed by physico-chemical biomaterial properties","volume":"234","author":"Dye","year":"2020","journal-title":"Biomaterials"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","article-title":"Modeling development and disease with organoids","volume":"165","author":"Clevers","year":"2016","journal-title":"Cell"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"5498","DOI":"10.1038\/s41467-021-25729-7","article-title":"A CRISPR\/Cas9 genetically engineered organoid biobank reveals essential host factors for coronaviruses","volume":"12","author":"Beumer","year":"2021","journal-title":"Nat Commun"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e105912","DOI":"10.15252\/embj.2020105912","article-title":"An organoid-derived bronchioalveolar model for SARS-CoV-2 infection of human alveolar type II-like cells","volume":"40","author":"Lamers","year":"2021","journal-title":"EMBO J"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.matbio.2018.03.021","article-title":"Idiopathic pulmonary fibrosis: epithelial-mesenchymal interactions and emerging therapeutic targets","author":"Hewlett","year":"2018","journal-title":"Matrix Biol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15283\/ijsc20093","article-title":"Organoid model in idiopathic pulmonary fibrosis","volume":"14","author":"Lee","year":"2021","journal-title":"Int J Stem Cells"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1182368","DOI":"10.3389\/fmed.2023.1182368","article-title":"Dysregulated cross-talk between alveolar epithelial cells and stromal cells in idiopathic pulmonary fibrosis reduces epithelial regenerative capacity","volume":"10","author":"Wisman","year":"2023","journal-title":"Front Med"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4046\/trd.2024.0094","article-title":"Regenerative capacity of alveolar type 2 cells is proportionally reduced following disease progression in idiopathic pulmonary fibrosis-derived organoid cultures","volume":"88","author":"Choi","year":"2025","journal-title":"Tuberc Respir Dis"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.2147\/JIR.S280958","article-title":"Genetic risk factors for idiopathic pulmonary fibrosis: insights into Immunopathogenesis","volume":"13","author":"Michalski","year":"2020","journal-title":"J Inflamm Res"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1165\/rcmb.2022-0315OC","article-title":"Loss of ANT1 increases fibrosis and epithelial cell senescence in idiopathic pulmonary fibrosis","volume":"69","author":"Sui","year":"2023","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s10020-024-00990-w","article-title":"Co-culture of human AT2 cells with fibroblasts reveals a MUC5B phenotype: insights from an organoid model","volume":"30","author":"Yao","year":"2024","journal-title":"Mol Med"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"00679","DOI":"10.1183\/23120541.00679-2022","article-title":"Interleukin-11 disrupts alveolar epithelial progenitor function","volume":"9","author":"Kortekaas","year":"2023","journal-title":"ERJ Open Res"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1136\/thoraxjnl-2020-214986","article-title":"Pretreatment of aged mice with retinoic acid supports alveolar regeneration via upregulation of reciprocal PDGFA signalling","volume":"76","author":"Gokey","year":"2021","journal-title":"Thorax"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"e202201853","DOI":"10.26508\/lsa.202201853","article-title":"Modeling fibrotic alveolar transitional cells with pluripotent stem cell-derived alveolar organoids","volume":"6","author":"Ptasinski","year":"2023","journal-title":"Life Sci Alliance"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2174\/1566523220666201012145731","article-title":"CRISPR\/Cas9 genome editing tool: a promising tool for therapeutic applications on respiratory diseases","volume":"20","author":"Shaikh","year":"2020","journal-title":"Curr Gene Ther"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10555-016-9618-0","article-title":"Progression and metastasis of lung cancer","volume":"35","author":"Popper","year":"2016","journal-title":"Cancer Metastasis Rev"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00418-020-01955-w","article-title":"Lung organoids: advances in generation and 3D-visualization","volume":"155","author":"Cunniff","year":"2021","journal-title":"Histochem Cell Biol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3892\/or.2018.6501","article-title":"Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissues","volume":"40","author":"Tamura","year":"2018","journal-title":"Oncol Rep"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"E11671","DOI":"10.1073\/pnas.1803718115","article-title":"Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer coculture","volume":"115","author":"Chen","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.cell.2018.07.009","article-title":"Generation of tumor-reactive T cells by co-culture of peripheral blood lymphocytes and tumor organoids","volume":"174","author":"Dijkstra","year":"2018","journal-title":"Cell"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"101777","DOI":"10.1016\/j.xcrm.2024.101777","article-title":"Modeling lung adenocarcinoma metastases using patient-derived organoids","volume":"5","author":"Liu","year":"2024","journal-title":"Cell Rep Med"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.cell.2018.11.021","article-title":"Organoid modeling of the tumor immune microenvironment","volume":"175","author":"Neal","year":"2018","journal-title":"Cell"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1038\/s41467-024-47737-z","article-title":"A patient-specific lung cancer assembloid model with heterogeneous tumor microenvironments","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat Commun"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1039\/d3lc01044a","article-title":"Deciphering fibroblast-induced drug resistance in non-small cell lung carcinoma through patient-derived organoids in agarose microwells","volume":"24","author":"Luan","year":"2024","journal-title":"Lab Chip"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s41419-023-06198-w","article-title":"SAA suppresses \u03b1-PD-1 induced anti-tumor immunity by driving TH2 polarization in lung adenocarcinoma","volume":"14","author":"Wang","year":"2023","journal-title":"Cell Death Dis"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s42003-024-06190-w","article-title":"Genome-wide CRISPR screens identify the YAP\/TEAD axis as a driver of persister cells in EGFR mutant lung cancer","volume":"7","author":"Pfeifer","year":"2024","journal-title":"Commun Biol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1164\/rccm.201906-1190PP","article-title":"Targeting proteases in cystic fibrosis lung disease. Paradigms, Progress, and potential","volume":"201","author":"McKelvey","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.3390\/ijms23031437","article-title":"Assays of CFTR function in vitro, ex vivo and in vivo","volume":"23","author":"Ramalho","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1802379","DOI":"10.1183\/13993003.02379-2018","article-title":"Intestinal organoids to model cystic fibrosis","volume":"54","author":"van Mourik","year":"2019","journal-title":"Eur Respir J"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"6293","DOI":"10.3390\/ijms24076293","article-title":"Airway and lung organoids from human-induced pluripotent stem cells can be used to assess CFTR conductance","volume":"24","author":"Demchenko","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.stem.2017.03.001","article-title":"Efficient derivation of functional human airway epithelium from pluripotent stem cells via temporal regulation of Wnt signaling","volume":"20","author":"McCauley","year":"2017","journal-title":"Cell Stem Cell"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1336392","DOI":"10.3389\/fcell.2024.1336392","article-title":"Airway basal cells from human-induced pluripotent stem cells: a new frontier in cystic fibrosis research","volume":"12","author":"Demchenko","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"41","DOI":"10.70470\/SHIFAA\/2023\/005","article-title":"CRISPR-Cas9 mediated gene correction of CFTR mutations in cystic fibrosis: evaluating efficacy, safety, and long-term outcomes in patient-derived lung organoids","volume":"41","author":"D\u00f6larslan","year":"2023","journal-title":"SHIFAA"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"e0295009","DOI":"10.1371\/journal.pone.0295009","article-title":"Prime editing-mediated correction of the CFTR W1282X mutation in iPSCs and derived airway epithelial cells","volume":"18","author":"Li","year":"2023","journal-title":"PLoS One"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.omtn.2019.02.006","article-title":"Efficient gene editing at major CFTR mutation loci","volume":"16","author":"Ruan","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1039\/d0lc00644K","article-title":"A 96-well format microvascularized human lung-on-a-chip platform for microphysiological modeling of fibrotic diseases","volume":"20","author":"Mej\u00edas","year":"2020","journal-title":"Lab Chip"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jcf.2021.10.004","article-title":"Modeling pulmonary cystic fibrosis in a human lung airway-on-a-chip","volume":"21","author":"Plebani","year":"2022","journal-title":"J Cyst Fibros"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s44178-023-00041-0","article-title":"The impact of the COVID-19 pandemic on nasopharyngeal carcinoma patients \u2013 a national cancer Centre experience","volume":"2","author":"Poh","year":"2023","journal-title":"Holist Integr Oncol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"101874","DOI":"10.1016\/j.jchemneu.2020.101874","article-title":"Molecular characterization, pathogen-host interaction pathway and in silico approaches for vaccine design against COVID-19","volume":"110","author":"Singh","year":"2020","journal-title":"J Chem Neuroanat"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.stem.2020.10.004","article-title":"Three-dimensional human alveolar stem cell culture models reveal infection response to SARS-CoV-2","volume":"27","author":"Youk","year":"2020","journal-title":"Cell Stem Cell"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.stem.2020.10.005","article-title":"Human lung stem cell-based Alveolospheres provide insights into SARS-CoV-2-mediated interferon responses and Pneumocyte dysfunction","volume":"27","author":"Katsura","year":"2020","journal-title":"Cell Stem Cell"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"e64508","DOI":"10.7554\/eLife.64508","article-title":"SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site","volume":"10","author":"Mykytyn","year":"2021","journal-title":"eLife"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"2276338","DOI":"10.1080\/22221751.2023.2276338","article-title":"Low level of tonic interferon signalling is associated with enhanced susceptibility to SARS-CoV-2 variants of concern in human lung organoids","volume":"12","author":"Flagg","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2901-9","article-title":"Identification of SARS-CoV-2 inhibitors using lung and colonic organoids","volume":"589","author":"Han","year":"2021","journal-title":"Nature"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"e106057","DOI":"10.15252\/embj.2020106057","article-title":"Cholesterol 25-hydroxylase inhibits SARS-CoV-2 and other coronaviruses by depleting membrane cholesterol","volume":"39","author":"Wang","year":"2020","journal-title":"EMBO J"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.stem.2020.11.009","article-title":"Androgen signaling regulates SARS-CoV-2 receptor levels and is associated with severe COVID-19 symptoms in men","volume":"27","author":"Samuel","year":"2020","journal-title":"Cell Stem Cell"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s13238-020-00811-w","article-title":"Host metabolism dysregulation and cell tropism identification in human airway and alveolar organoids upon SARS-CoV-2 infection","volume":"12","author":"Pei","year":"2021","journal-title":"Protein Cell"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.3390\/v13122489","article-title":"Synergistic interferon-alpha-based combinations for treatment of SARS-CoV-2 and other viral infections","volume":"13","author":"Ianevski","year":"2021","journal-title":"Viruses"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3390\/v13040651","article-title":"Screening of FDA-approved drugs using a MERS-CoV clinical isolate from South Korea identifies potential therapeutic options for COVID-19","volume":"13","author":"Ko","year":"2021","journal-title":"Viruses"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"e107651","DOI":"10.15252\/embj.2021107651","article-title":"Halting SARS-CoV-2: lung organoids step up to the plate","volume":"40","author":"Leibel","year":"2021","journal-title":"EMBO J"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"e164720","DOI":"10.1172\/jci.insight.179745","article-title":"Circadian regulation of lung repair and regeneration","volume":"8","author":"Naik","year":"2023","journal-title":"JCI Insight"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ydbio.2022.12.001","article-title":"Human lung organoid: models for respiratory biology and diseases","volume":"494","author":"Yang","year":"2023","journal-title":"Dev Biol"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1038\/s41467-022-29647-0","article-title":"Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration","volume":"13","author":"Li","year":"2022","journal-title":"Nat Commun"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1002\/bit.28166","article-title":"3D printed human organoids: high throughput system for drug screening and testing in current COVID-19 pandemic","volume":"119","author":"Parihar","year":"2022","journal-title":"Biotechnol Bioeng"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"302","DOI":"10.18063\/ijb.v6i4.302","article-title":"Engineering a model to study viral infections: bioprinting, microfluidics, and organoids to defeat coronavirus disease 2019 (COVID-19)","volume":"6","author":"Shpichka","year":"2020","journal-title":"Int J Bioprint"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.1021\/acs.accounts.1c00411","article-title":"Microfluidic organs-on-a-chip for modeling human infectious diseases","volume":"54","author":"Wang","year":"2021","journal-title":"Acc Chem Res"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"e2105187","DOI":"10.1002\/advs.202105187","article-title":"Human organoids and organs-on-chips for addressing COVID-19 challenges","volume":"9","author":"Wang","year":"2022","journal-title":"Adv. Sci"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"e29579","DOI":"10.1002\/jmv.29579","article-title":"The use of human iPSC-derived alveolar organoids to explore SARS-CoV-2 variant infections and host responses","volume":"96","author":"Gandikota","year":"2024","journal-title":"J Med Virol"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"111220","DOI":"10.1016\/j.celrep.2022.111220","article-title":"SARS-CoV-2 spike N-terminal domain modulates TMPRSS2-dependent viral entry and fusogenicity","volume":"40","author":"Meng","year":"2022","journal-title":"Cell Rep"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"e0059422","DOI":"10.1128\/jvi.00594-22","article-title":"SARS-CoV-2 variants of concern hijack IFITM2 for efficient replication in human lung cells","volume":"96","author":"Nchioua","year":"2022","journal-title":"J Virol"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"2211685","DOI":"10.1080\/22221751.2023.2211685","article-title":"Reciprocal enhancement of SARS-CoV-2 and influenza virus replication in human pluripotent stem cell-derived lung organoids1","volume":"12","author":"Kim","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.bioactmat.2024.05.019","article-title":"Dynamic microphysiological system chip platform for high-throughput, customizable, and multi-dimensional drug screening","volume":"39","author":"Zhu","year":"2024","journal-title":"Bioact Mater"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3390\/cancers13040737","article-title":"Microfluidic organoids-on-a-Chip: quantum leap in Cancer research","volume":"13","author":"Duzagac","year":"2021","journal-title":"Cancers"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"1205157","DOI":"10.3389\/fbioe.2023.1205157","article-title":"Patient-derived organoids of lung cancer based on organoids-on-a-chip: enhancing clinical and translational applications","volume":"11","author":"Zeng","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"10092","DOI":"10.1021\/acs.analchem.4c02075","article-title":"A microfluidic Chip-based automated system for whole-course monitoring the drug responses of organoids","volume":"96","author":"Zhang","year":"2024","journal-title":"Anal Chem"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"17027","DOI":"10.1021\/acs.analchem.4c05111","article-title":"Microfluidic Chip-based automatic system for sequencing patient-derived organoids at the single-cell level","volume":"96","author":"Wu","year":"2024","journal-title":"Anal Chem"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"4832","DOI":"10.3390\/cancers13194832","article-title":"Primary lung Cancer organoids for personalized medicine-are they ready for clinical use?","volume":"13","author":"Werner","year":"2021","journal-title":"Cancers"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41420-021-00439-7","article-title":"Human pluripotent stem-cell-derived alveolar organoids for modeling pulmonary fibrosis and drug testing","volume":"7","author":"Kim","year":"2021","journal-title":"Cell Death Discov"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1088\/1758-5090\/acee21","article-title":"Highly reproducible and cost-effective one-pot organoid differentiation using a novel platform based on PF-127 triggered spheroid assembly","volume":"15","author":"Zhang","year":"2023","journal-title":"Biofabrication"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"012006","DOI":"10.1088\/1758-5090\/AD91E2","article-title":"Integration of bioprinting advances and biomechanical strategies forin vitrolung modelling","volume":"17","author":"Avery","year":"2024","journal-title":"Biofabrication"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1056\/NEJMc1903253","article-title":"Organoids \u2013 preclinical models of human disease","volume":"380","author":"Ballard","year":"2019","journal-title":"N Engl J Med"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s13287-022-02950-9","article-title":"Organoids: a systematic review of ethical issues","volume":"13","author":"de Jongh","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1242\/dev.140111","article-title":"Ethical issues in human organoid and gastruloid research","volume":"144","author":"Munsie","year":"2017","journal-title":"Development"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00109-021-02053-7","article-title":"The ethics of human-embryoids model: a call for consistency","volume":"99","author":"Nicolas","year":"2021","journal-title":"J Mol Med (Berl)"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"e2400185","DOI":"10.1002\/advs.202400185","article-title":"Patient-derived tumor organoids combined with function-associated ScRNA-Seq for dissecting the local immune response of lung Cancer","volume":"11","author":"Liu","year":"2024","journal-title":"Adv Sci"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1089\/ten.TEA.2019.0251","article-title":"Global Trends of Organoid and Organ-On-a-Chip in the Past Decade: A Bibliometric and Comparative Study","volume":"26","author":"Wang","year":"2020","journal-title":"Tissue Eng Part A."},{"key":"ref106","doi-asserted-by":"publisher","first-page":"609452","DOI":"10.3389\/fcell.2021.609452","article-title":"Current Trends and Research Topics Regarding Intestinal Organoids: An Overview Based on Bibliometrics","volume":"9","author":"Zhang","year":"2021","journal-title":"Front Cell Dev Biol."},{"key":"ref107","doi-asserted-by":"publisher","first-page":"e13239","DOI":"10.1111\/cpr.13239","article-title":"Knowledge graphs of ethical concerns of cerebral organoids","volume":"55","author":"Ding","year":"2022","journal-title":"Cell Prolif."},{"key":"ref108","doi-asserted-by":"publisher","first-page":"888956","DOI":"10.3389\/fsurg.2022.888956","article-title":"Global Trends of Stem Cell Precision Medicine Research (2018-2022): A Bibliometric Analysis","volume":"9","author":"Liu","year":"2022","journal-title":"Front Surg."},{"key":"ref109","doi-asserted-by":"publisher","first-page":"104728","DOI":"10.1016\/j.isci.2022.104728","article-title":"Patent bibliometric analysis for global trend of organoid technologies in the past decade","volume":"25","author":"Zhu","year":"2022","journal-title":"iScience."},{"key":"ref110","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.21037\/apm-22-290","article-title":"Global trends and hotspots in research on organoids between 2011 and 2020: a bibliometric analysis","volume":"11","author":"Zhang","year":"2022","journal-title":"Ann Palliat Med."},{"key":"ref111","doi-asserted-by":"publisher","first-page":"1092870","DOI":"10.3389\/fonc.2023.1092870","article-title":"Progress of research on tumor organoids: A bibliometric analysis of relevant publications from 2011 to 2021","volume":"13","author":"Shuoxin","year":"2023","journal-title":"Front Oncol."},{"key":"ref112","doi-asserted-by":"publisher","first-page":"e13496","DOI":"10.1111\/cpr.13496","article-title":"Development trends of human organoid-based COVID-19 research based on bibliometric analysis","volume":"56","author":"Li","year":"2023","journal-title":"Cell Prolif."},{"key":"ref113","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13567-024-01333-7","article-title":"Mapping the scientific output of organoids for animal and human modeling infectious diseases: a bibliometric assessment","volume":"55","author":"Yan","year":"2024","journal-title":"Vet Res."},{"key":"ref114","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.4103\/1673-5374.390972","article-title":"Human brain organoid: trends, evolution, and remaining challenges","volume":"19","author":"Li","year":"2024","journal-title":"Neural Regen Res."},{"key":"ref115","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1007\/s00204-024-03777-4","article-title":"Applications of 3D organoids in toxicological studies: a comprehensive analysis based on bibliometrics and advances in toxicological mechanisms","volume":"98","author":"Yang","year":"2024","journal-title":"Arch Toxicol."},{"key":"ref116","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.reth.2024.02.004","article-title":"Bibliometric and visualized analysis of hydrogels in organoids research","volume":"25","author":"Wang","year":"2024","journal-title":"Regen Ther."},{"key":"ref117","doi-asserted-by":"publisher","first-page":"1433111","DOI":"10.3389\/fcell.2024.1433111","article-title":"Interpretation of the past, present, and future of organoid technology: an updated bibliometric analysis from 2009 to 2024","volume":"12","author":"Qu","year":"2024","journal-title":"Front Cell Dev Biol."},{"key":"ref118","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41579-022-00713-0","article-title":"SARS-CoV-2 pathogenesis","volume":"20","author":"Lamers","year":"2022","journal-title":"Nat Rev Microbiol."},{"key":"ref119","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nature25786","article-title":"Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor","volume":"555","author":"Zacharias","year":"2018","journal-title":"Nature."},{"key":"ref120","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1172\/JCI57673","article-title":"Integrin \u03b16\u03b24 identifies an adult distal lung epithelial population with regenerative potential in mice","volume":"121","author":"Chapman","year":"2011","journal-title":"J Clin Invest."},{"key":"ref121","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.drudis.2016.07.003","article-title":"Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling","volume":"21","author":"Skardal","year":"2016","journal-title":"Drug Discov Today."},{"key":"ref122","doi-asserted-by":"publisher","first-page":"8837","DOI":"10.1038\/s41598-017-08879-x","article-title":"Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform","volume":"7","author":"Skardal","year":"2017","journal-title":"Sci Rep."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1611304\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T04:12:12Z","timestamp":1752639132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1611304\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":122,"alternative-id":["10.3389\/fmed.2025.1611304"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1611304","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"article-number":"1611304"}}